X
23Jan

Blog: Cooley's 2019 Life Sciences M&A Year in Review

Cooley LLP | | Return|
2019 was a banner year for billion-dollar life sciences M&A transactions. A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in...
By: Cooley LLP
Source Url: https://www.jdsupra.com/legalnews/blog-cooley-s-2019-life-sciences-m-a-13105/

Related

Competition Newsletter - More flexible approach to non-compete clauses related to investments in startups

On June 19, 2020, the Hungarian Competition Authority (“GVH”) adopted a decision providing guidanc...

Read More >

20 Steps To Avoid Employment Lawsuits

I have been asked by more than one frustrated California employer how to avoid or reduce employment ...

Read More >

Foreign direct investment reviews 2020: A global perspective - United States

Most deals are approved, but new rules covering more types of transactions and requiring mandatory f...

Read More >

[Video] The Reintroduction of Net Operating Loss - A Pepper Hamilton and Financial Executives Alliance Webinar

Recent law changes can provide portfolio company liquidity and/or require reconsideration of 2018–2...

Read More >

Green Buildings in the Economic Recovery

As Canada takes steps towards economic recovery from the COVID-19 pandemic, the health and safety co...

Read More >

Construction-Manager-As-Constructor Recognized as an Acceptable Project Delivery Method in Federal Contracts

On December 19, 2019, the U.S. General Services Administration (“GSA”) issued a final rule which a...

Read More >